<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="16040">Cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi>, 3 g/m2, every 12 h for 6 days, followed by fractionated total body irradiation, 200 cGy twice daily for 3 days, was administered to 39 adult patients undergoing bone marrow transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>Allogeneic transplant patients received cyclosporin and <z:chebi fb="0" ids="44185">methotrexate</z:chebi> for prophylaxis of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>There were 21 autologous transplants (16 with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, four with an advanced stage of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and one with <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) and 18 allogeneic transplants (14 with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, two with an advanced stage of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and two with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>Toxicities were compared between the two groups </plain></SENT>
<SENT sid="4" pm="."><plain>There was a significantly greater degree and duration of mucositis and a greater frequency of radiation-type <z:hpo ids='HP_0000488'>retinopathy</z:hpo> developing in the allogeneic group, predominantly in those having had radiation for prophylaxis or treatment of central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Seven of 11 <z:hpo ids='HP_0011009'>acute</z:hpo> leukemic patients who received autologous transplants in remission survive </plain></SENT>
<SENT sid="6" pm="."><plain>Two of seven <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> who received allogeneic transplants while in remission survive </plain></SENT>
<SENT sid="7" pm="."><plain>Although the increased morbidity, <z:e sem="disease" ids="C0035333" disease_type="Disease or Syndrome" abbrv="">retinitis</z:e> and mucositis, observed in the allogeneic group indicates that this regimen when combined with <z:chebi fb="0" ids="44185">methotrexate</z:chebi> and cyclosporin is too toxic, the results in autologous transplantation in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> in remission are encouraging </plain></SENT>
</text></document>